SCHEMBL285034

SCHEMBL285034

C=COC(=O)OCC(C)C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.57
ALDH1A1 P00352 4/20 0.38
TDP1 Q9NUW8 3/20 0.37
CYP3A4 P08684 3/20 0.37
LMNA P02545 2/20 0.37
MEN1 O00255 1/20 0.37
CYP2C9 P11712 1/20 0.37
NFKB1 P19838 1/20 0.37
PTGS1 P23219 1/20 0.37
APEX1 P27695 1/20 0.37
THPO P40225 1/20 0.37
PMP22 Q01453 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.33
HPGD P15428 2/20 0.31
MAPT P10636 3/20 0.31
USP2 O75604 2/20 0.31
RECQL P46063 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29008011 0.82 MAPT (0.41) TSHRALDH1A1MAPT
SCHEMBL7417774 0.80 TSHR (0.48) TSHRALDH1A1TDP1CYP3A4LMNA
SCHEMBL304126 0.80 TSHR (0.48) TSHRALDH1A1TDP1CYP3A4LMNA
SCHEMBL575321 0.78 TSHR (0.33) TSHR
SCHEMBL320955 0.78 TSHR (0.33) TSHR
SCHEMBL4203569 0.78 TSHR (0.47) TSHRALDH1A1TDP1CYP3A4LMNA
SCHEMBL25435787 0.78 TSHR (0.54) TSHRALDH1A1TDP1CYP3A4LMNA
SCHEMBL37351 0.78 TSHR (0.54) TSHRALDH1A1TDP1CYP3A4LMNA
SCHEMBL8675193 0.78 TSHR (0.52) TSHRALDH1A1TDP1SMN1; SMN2L3MBTL1
SCHEMBL8206945 0.77 TSHR (0.35) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750405-A ALBUMIN DETECTION IN URINE WITH QUANTITATIVE ANALYSIS BAYER CORPORATION (US) 1998-05-12 US claimed
EP-0793099-A1 Improved method for the detection of protein Bayer Corporation (US) 1997-09-03 EP claimed
EP-3091050-B1 THIOL-ENE POLYMERIZATION WITH VINYLESTERS AND VINYLCARBONATE SYNTHES GMBH (CH) 2018-07-18 EP disclosed
US-9814801-B2 Thiol-ene polymerization with vinylesters and vinylcarbonate DePuy Synthes Products, Inc. (US) 2017-11-14 US disclosed
US-9623145-B2 Thiol-ene polymerization with vinylesters and vinylcarbonate DePuy Synthes Products, Inc. (US) 2017-04-18 US disclosed
EP-3091050-A1 THIOL-ENE POLYMERIZATION WITH VINYLESTERS AND VINYLCARBONATE Synthes GmbH (CH) 2016-11-09 EP disclosed
US-20160243279-A1 THIOL-ENE POLYMERIZATION WITH VINYLESTERS AND VINYLCARBONATE SYNTHES GMBH (CH) 2016-08-25 US disclosed
EP-2764049-B1 THIOL-ENE POLYMERIZATION WITH VINYLESTERS AND VINYLCARBONATE SYNTHES GMBH (CH) 2016-08-17 EP disclosed
US-8999323-B2 Composition that can be cured by polymerisation for the production of biodegradable, biocompatible, cross-linkable polymers on the basis of polyvinyl alcohol TECHNISCHE UNIVERSITÄT WIEN (AT) 2015-04-07 US disclosed
EP-2764049-A1 THIOL-ENE POLYMERIZATION WITH VINYLESTERS AND VINYLCARBONATE Synthes GmbH (CH) 2014-08-13 EP disclosed
EP-2428235-B1 Use of compounds hardened by means of polymerisation for producing biodegradable, biocompatible, networked polymers UNIV WIEN TECH (AT) 2014-06-04 EP disclosed
US-20130084543-A1 THIOL-ENE POLYMERIZATION WITH VINYLESTERS AND VINYLCARBONATE TECHNISCHE UNIVERSITAT WIEN (AT) 2013-04-04 US disclosed
EP-2428235-A2 Use of compounds hardened by means of polymerisation for producing biodegradable, biocompatible, networked polymers Technische Universität Wien (AT) 2012-03-14 EP disclosed
US-20100303804-A1 COMPOSITION THAT CAN BE CURED BY POLYMERISATION FOR THE PRODUCTION OF BIODEGRADABLE, BIOCOMPATIBLE, CROSS-LINKABLE POLYMERS ON THE BASIS OF POLYVINYL ALCOHOL TECHNISCHE UNIVERSITAT WIEN (AT) 2010-12-02 US disclosed
EP-2219697-A2 COMPOSITION THAT CAN BE CURED BY POLYMERISATION FOR THE PRODUCTION OF BIODEGRADABLE, BIOCOMPATIBLE, CROSS-LINKABLE POLYMERS ON THE BASIS OF POLYVINYL ALCOHOL Technische Universität Wien (AT) 2010-08-25 EP disclosed
WO-2009065162-A2 COMPOSITION THAT CAN BE CURED BY POLYMERISATION FOR THE PRODUCTION OF BIODEGRADABLE, BIOCOMPATIBLE, CROSS-LINKABLE POLYMERS ON THE BASIS OF POLYVINYL ALCOHOL TECHNISCHE UNIVERSITÄT WIEN (AT) 2009-05-28 WO disclosed
EP-0396364-B1 Copolymers of vinyl carbonate and vinyl carbamate as contact lens material BAUSCH & LOMB (US) 1997-06-11 EP disclosed
US-5610252-A Vinyl carbonate and vinyl carbamate contact lens material monomers BAUSCH & LOMB INCORPORATED (US) 1997-03-11 US disclosed
US-5070215-A Gas permeable contact lenses BAUSCH & LOMB INCORPORATED (US) 1991-12-03 US disclosed
EP-0396364-A2 Novel vinyl carbonate and vinyl carbamate contact lens material monomers BAUSCH & LOMB INCORPORATED (US) 1990-11-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130084543-A1 THIOL-ENE POLYMERIZATION WITH VINYLESTERS AND VINYLCARBONATE TMT1A, MGMT, CBS TSHR 2137/4885ALDH1A1 335/4885TDP1 1571/4885
US-20100303804-A1 COMPOSITION THAT CAN BE CURED BY POLYMERISATION FOR THE PRODUCTION OF BIODEGRADABLE, BIOCOMPATIBLE, CROSS-LINKABLE POLYMERS ON THE BASIS OF POLYVINYL ALCOHOL SCO2, CBR1, CBR3 TSHR 4555/4885ALDH1A1 822/4885TDP1 3960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.